Antifungal Drugs Market: Extensively Stable and Large Setup of Businesses makes North America a Leading Region

The global antifungal drugs market is expected to witness a significant growth, as per a recent study carried by Transparency Market Research. The report, titled, “Antifungal Drugs Market – Global Industry Analysis, Market Size, Share, Trends, Analysis, Growth, and Forecast 2016 – 2024,” comprehensively outlines this study and presents the findings in substantial detail.

The global antifungal drugs market is mainly driven by deteriorating and unhygienic conditions that exist in some regions around the globe. This is especially seen in highly populated and underdeveloped economies where slums full of squalor-like conditions exist. Several antifungal drugs are commonly available over-the-counter, which is a prominent growth driver for the global antifungal market. Many of these drugs have a significantly positive effect, which makes their demand higher, thus proving beneficial to the market’s rise. Even favorable government initiatives and funding have managed to provide a tailwind to the market.

Based on regions, the global antifungal drugs market is divided into four segments: Europe, North America, Asia Pacific, and Rest of the World. Among all these, North America holds maximum share in the market owing to chief market players being domiciled in the U.S. and Canada. Extensive research and development is also responsible for more innovations, thus contributing towards a better future for the market.

Most companies operating in the global antifungal drugs market are putting a lot of emphasis on adding to their product portfolios. Presence of quite a few well-known players in the global antifungal drugs market makes the competition substantially tough, which has resulted in implementation of various strategies by players to beat competition. Mergers and acquisitions to strengthen their position in the market is one of them. GlaxoSmithKline Plc, Merck & Co. Inc., Enzon Pharmaceuticals, Inc., Sigma-Aldrich, Bayer AG, Novartis AG, Pfizer, Inc., and Sanofi-Aventis are a few prominent players present in the global antifungal drugs market.

To Get a Brochure @

Leave a Reply